Home / Hospital Supplies / Pancreatic Cancer Diagnostics Using Artificial Intelligence for Hospitals: Market Shares, Strategies, and Forecasts, Worldwide, 2017 to 2023

Pancreatic Cancer Diagnostics Using Artificial Intelligence for Hospitals: Market Shares, Strategies, and Forecasts, Worldwide, 2017 to 2023

Published: Oct 2017 | No Of Pages: 75 | Published By: Winter Green Research

WinterGreen Research announces that it has published a new study Pancreatic Cancer Diagnostics Using Artificial Intelligence: Market Shares, Strategy, and Forecasts, Worldwide, 2017 to 2023.  The 2017 study has 75 pages, 28 tables and figures.  Worldwide markets are poised to achieve continuing growth as the artificial intelligence software increases diagnostic excellence, saving lives and lowering care delivery costs. 

Automated cancer diagnostics are implemented with artificial intelligence.  Systems are able to take a multi-disciplinary integrated approach to looking at imaging and scans.  The analysis of patient records, looking for effectiveness of particular treatments is more work than a human can do, the quantity of data is too high, so the artificial intelligence is being used to do that.  
Systems are making a significant difference in saving lives.  

Much of the hospital artificial intelligence market is centered on improving diagnosis and treatment of cancer through the visualization provided by radiology.  The systems are able to track and analyze more data, more accurately than can the humans.  Radiologists receive years of training.  They are among the highest paid doctors, also among the first group of physicians utilizing artificial intelligence because of the complexity of the task to be done. 

According to Susan Eustis, lead author of the team that wrote the study, “Artificial intelligence expands into health care leveraging insight from radiological studies and diagnostics.  Radiologists have a deluge of patient data that the artificial intelligence can manage in some ways.  This contributes to earlier cancer diagnosis.”

Artificial Intelligence for Hospital Cancer Diagnostics Market Forecasts
AI is set to become a sophisticated diagnostic aid, flagging images that humans should examine more closely, while leaving radiologists with more time for interacting with patients and medical staff.
Hospital artificial intelligence market shipments at $1.7 billion in 2023 are forecast to reach $11.4 billion dollars, worldwide 2023.  

WinterGreen Research is an independent research organization funded by the sale of market research studies all over the world and by the implementation of ROI models that are used to calculate the total cost of ownership of equipment, services, and software.  The company has 35 distributors worldwide, including Global Information Info Shop, Market Research.com, Research and Markets, electronics.ca, Bloomberg, and Thompson Financial.  

WinterGreen Research is positioned to help customers facing challenges that define the modern enterprises. The increasingly global nature of science, technology and engineering is a reflection of the implementation of the globally integrated enterprise.  Customers trust wintergreen research to work alongside them to ensure the success of the participation in a particular market segment.

WinterGreen Research supports various market segment programs; provides trusted technical services to the marketing departments.  It carries out accurate market share and forecast analysis services for a range of commercial and government customers globally.  These are all vital market research support solutions requiring trust and integrity.

1. Artificial Intelligence Cancer Diagnostics Market Description and Market Dynamics: 12
1.1 Artificial Intelligence Very Big Breakthrough in Cancer Diagnostics 12
1.2 Ability of AI Solutions To Discover Schemas in Large Databases 13

2. Artificial Intelligence (AI) Cancer Diagnostics Market Driving Forces 15
2.1 Artificial Intelligence (AI) Cancer Diagnostics Market Driving Forces 15
2.2 Artificial Intelligence Cancer Diagnostics Market Shares: 17
2.3 Artificial Intelligence for Cancer Diagnostics Market Forecasts: 18
2.4 Cancer Statistics 25
2.5 Hospital Artificial Intelligence (AI) Challenges 28
2.6 Hospital Artificial Intelligence Software Prices: 33
2.7 Hospital Artificial Intelligence Regional Segments: 34

3. Hospital Artificial Intelligence Products: 36
3.1 Partners HealthCare, IBM, and GE Healthcare 36
3.2 IBM Watson 38
3.2.1 IBM Genomic And Immunotherapy Supercomputing for Patient
Management 41
3.2.2 Mayo Clinic and IBM Watson 42
3.3 Google’s AI Subsidiary DeepMind is Partnering With Another UK hospital 44
3.4 Prognos 44

4. Hospital Artificial Intelligence Research and Technology: 45
4.1 Research at Google 45
4.2 IBM AI Research 46
4.2.1 Neural Representation of Sketch Drawings 47
4.3 Google and Nvidia Artificial Intelligence 48

5. Hospital Artificial Intelligence Companies 49
5.1 Alphabet / Google 49
5.1.1 Google Artificial Intelligence Subsidiary DeepMind
Healthcare Initiative 49
5.2 General Electric (GE) 50
5.2.1 General Electric Revenue by Segment 50
5.2.2 GE Healthcare and Massachusetts General Artificial Intelligence 51
5.3 IBM 54
5.3.1 IBM Watson Genomics by Quest Diagnostics 55
5.3.2 IBM Watson Healthcare Revenue 57
5.3.3 IBM Watson Solutions Software Healthcare Revenue 57
5.4 Prognos 58
5.4.1 Coding Healthcare Datasets Full Of Unstructured Text 61
5.5 Quest Diagnostics 65
5.5.1 IBM Personalized Healthcare: Watson Genomics from Quest
Diagnostics 66
5.5.2 Quest Diagnostics Revenue 67
5.6 Safeguard Scientifics Announces Second Quarter 2017 Financial Results 67
5.6.1 Safeguard Scientifics Prognos DxCloud 68

Figure 1. Artificial Intelligence Cancer Diagnostics Market Shares, Software,
Dollars,
Worldwide, 2016 9
Figure 2. Artificial Intelligence for Cancer Diagnosis Market Shipments Forecasts
Dollars,
Worldwide, 2017-2023 11
Figure 3. Cancer Artificial Intelligence Components 14
Figure 4. Hospital Artificial Intelligence Predictive Functions 14
Figure 5. Artificial Intelligence Cancer Diagnostics (AI) Market Driving Forces 15
Figure 6. Healthcare Safety Features Implemented by Artificial Intelligence (AI)16
Figure 7. Artificial Intelligence Cancer Diagnostics Market Shares, Software,
Dollars,
Worldwide, 2016 17
Figure 8. Artificial Intelligence for Cancer Diagnostics Market Shares, Dollars,
Worldwide, 2016 18
Figure 9. Artificial Intelligence for Cancer Diagnostics Market Shipments
Forecasts Dollars, Worldwide, 2017-2023 20
Figure 10. Artificial Intelligence for Cancer Diagnostics Market Shipments
Forecasts Dollars, Worldwide, 2017-2023 21
Figure 11. AI Replacements for Supervised Manual Techniques For Diagnosis And
Care Delivery. 22
Figure 12. Hospital Artificial Intelligence Long-Term Goal 23
Figure 13. Hospital Artificial intelligence Action Functions 24
Figure 14. Pancreatic Cancer Survival Rate 27
Figure 15. Hospital Artificial Intelligence (AI) Challenges 29
Figure 16. Hospital Artificial Intelligence (AI) Human Factors 29
Figure 17. Hospital Artificial Intelligence Software, US and Worldwide,
Shipments Forecast, Dollars, Worldwide, 2017-2019 32
Figure 18. Hospital Artificial Intelligence Regional Market Segments, 2016 34
Figure 19. Hospital Artificial Intelligence Regional Market Segments, 2016 35
Figure 20. Truven Health Analytics Products 40
Figure 21. IBM TrueNorth Neurosynaptic System 46
Figure 22. AI Makes Words Manageable 47
Figure 23. GE Healthcare and Massachusetts General Artificial Intelligence
Healthcare Initiative Workflow 52
Figure 24. GE Healthcare and Massachusetts General Artificial Intelligence
Healthcare Initiative Center of Excellence 53
Figure 25. Prognos Investors 59
Figure 26. Percent Patients with Abnormally High Test 5 years Prior to First
Pancreatic Cancer Diagnosis Stratified by Test and by Year 63
Figure 27. Prognos Pancreatic Cancer Diagnosis Test Result Variance 64
Figure 28. Watson Genomics from Quest Diagnostics Features: 66

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +